Intracerebroventricular injections of Nec‐1 (a specific inhibitor of RIPK1) can prematurely reduce the volume of cerebral infarction more effectively compared with the therapeutic effects noted by the inhibition of apoptosis.12, 13. This evidence concerns the gene RIPK1 and brain infarction.